Hims & Hers Health, Inc.
HIMSHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Jun 1, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Hims & Hers Health, Inc. focuses on Drug Manufacturers - Specialty & Generic services and products. Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of. At a $6.05B market cap, Hims & Hers Health, Inc. ranks as a mid-cap company within healthcare. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Market Cap
$6.05B
Beta
2.42
P/E (TTM)
—
P/E (Fwd)
20.32
EPS (TTM)
$-0.09
EPS (Fwd)
$1.29
ROE
-2.7%
ROA
0.6%
Cash
$750.9M
Total Debt
$1.13B
Free CF
$174.3M
52W Change
-53.9%
Annual Financials
Cash vs Debt
On the balance sheet, HIMS has $750.9M in cash with $1.13B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $174.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -2.7% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $526.9M (2022) to $2.35B (2025), reflecting a 346% increase over the period.
A beta of 2.42 means HIMS is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Hims & Hers Health, Inc.'s trajectory.